Taok1 (NM_144825) Mouse Untagged Clone

CAT#: MC223157

Taok1 (untagged) - Mouse TAO kinase 1 (Taok1), (10ug)



  "NM_144825" in other vectors (4)

CNY 12,920.00


货期*
7周

规格
    • 10 ug

Product images

经常一起买 (3)
TurboFectin Transfection Reagent (1 mL in 1 vial)
    • 1 ml in 1 vial

CNY 4,090.00


DH5α Chemically Competent Cells (≥10^8 cfu/μg of pUC19 DNA)
    • 5 x 200 ul

CNY 1,280.00


Forward sequencing primer VP1.5, Reverse sequencing primer XL39, 100pmoles each
    • 100 pmol

CNY 480.00

Specifications

Product Data
Type Mouse Untagged Clone
Tag Tag Free
Synonyms 2810468K05Rik; AU020252; D130018F14Rik; Map3k16; Markk; mKIAA1361; Psk2
Vector pCMV6-Entry
E. coli Selection Kanamycin (25 ug/mL)
Mammalian Cell Selection Neomycin
Sequence Data
>MC223157 representing NM_144825
Red=Cloning site Blue=ORF Orange=Stop codon

TTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTGGATCCGGTACCGAGGAGATCTGCC
GCCGCGATCGCC

ATGCCATCAACTAACAGAGCAGGCAGTCTAAAGGACCCTGAAATTGCAGAGCTCTTCTTCAAAGAAGATC
CGGAAAAGCTCTTCACAGATCTCAGAGAAATCGGCCATGGGAGCTTTGGAGCAGTATATTTTGCACGAGA
TGTGCGTACTAATGAAGTGGTGGCCATCAAGAAAATGTCTTATAGTGGAAAGCAGTCTACTGAGAAATGG
CAGGATATTATTAAGGAAGTCAAGTTTCTACAAAGAATAAAACATCCCAACAGTATAGAATACAAAGGCT
GCTATTTACGTGAACACACAGCATGGCTTGTAATGGAATATTGTTTAGGATCTGCTTCAGATTTATTAGA
AGTTCATAAAAAGCCATTACAAGAAGTGGAAATAGCAGCAATTACACATGGTGCTCTCCAGGGACTAGCT
TATTTACATTCTCATACCATGATCCATAGAGATATCAAAGCAGGAAATATCCTTCTGACAGAACCAGGCC
AAGTGAAACTTGCTGACTTTGGATCTGCTTCCATGGCTTCCCCTGCCAATTCTTTTGTGGGAACACCATA
TTGGATGGCCCCAGAAGTAATTTTAGCCATGGATGAAGGACAGTATGATGGCAAAGTTGATGTATGGTCT
CTTGGAATAACGTGTATTGAATTAGCCGAGAGGAAGCCTCCTTTATTTAATATGAATGCAATGAGTGCCT
TATATCACATAGCCCAAAATGAATCCCCTACACTACAATCTAATGAATGGTCTGATTATTTTCGAAACTT
TGTAGATTCTTGCCTCCAGAAAATCCCTCAAGATCGCCCTACATCAGAGGAACTTTTAAAGCACATGTTT
GTTCTTCGAGAGCGCCCTGAAACAGTGTTAATAGATCTTATTCAAAGGACAAAGGATGCAGTAAGAGAGC
TGGACAATCTGCAGTATCGAAAGATGAAGAAACTCCTTTTCCAGGAGGCACATAATGGGCCAGCGGTAGA
AGCACAGGAAGAAGAGGAGGAGCAAGATCATGGTGTTGGCCGAACAGGAACAGTGAATAGTGTTGGAAGC
AATCAGTCTATCCCTAGTATGTCTATCAGTGCCAGCAGTCAAAGCAGCAGTGTTAATAGTCTTCCAGATG
CATCAGATGACAAGAGTGAGCTAGACATGATGGAGGGAGACCATACAGTGATGTCTAACAGTTCTGTCAT
CCACTTAAAACCTGAGGAGGAAAATTACCAGGAAGAAGGAGATCCTAGAACAAGAGCATCAGACCCACAG
TCTCCCCCTCAGGTGTCTCGTCACAAGTCACATTATCGTAATAGAGAACACTTTGCAACCATACGAACAG
CATCACTGGTTACAAGACAGATGCAAGAACATGAGCAGGACTCTGAACTTAGAGAACAGATGTCTGGTTA
TAAGCGGATGAGGCGACAGCATCAAAAGCAGCTGATGACGCTGGAAAATAAACTGAAGGCAGAGATGGAC
GAACATCGGCTCAGATTAGACAAAGATCTTGAAACTCAGCGTAACAATTTCGCTGCAGAAATGGAGAAAC
TTATTAAGAAACACCAAGCTGCTATGGAAAAAGAGGCTAAAGTGATGGCCAATGAGGAGAAAAAATTCCA
GCAACACATTCAGGCTCAACAGAAAAAAGAACTGAATAGCTTTTTGGAGTCTCAAAAAAGAGAATATAAA
CTTCGCAAAGAGCAGCTTAAGGAGGAGCTGAATGAAAACCAGAGCACACCTAAAAAAGAAAAGCAGGAAT
GGCTTTCAAAGCAGAAGGAGAATATACAGCATTTTCAGGCAGAAGAAGAAGCTAATCTTCTTCGACGTCA
AAGGCAGTATCTAGAGCTAGAATGTCGTCGCTTCAAAAGAAGAATGTTACTTGGGCGACATAACTTGGAA
CAGGACCTTGTCAGGGAGGAGTTAAACAAAAGGCAGACTCAAAAGGACTTGGAACATGCAATGCTATTGC
GACAGCATGAATCAATGCAAGAACTGGAGTTTCGCCATCTCAACACTATTCAGAAGATGCGCTGTGAGTT
GATCAGACTGCAGCATCAAACTGAGCTCACTAACCAGCTAGAGTACAATAAGAGAAGGGAACGGGAACTG
AGGCGAAAACATGTCATGGAAGTTCGACAACAACCTAAGAGTCTGAAGTCTAAAGAACTCCAAATAAAAA
AGCAGTTTCAGGATACCTGCAAAATTCAAACCAGACAGTACAAAGCATTAAGGAATCACCTACTGGAGAC
TACACCAAAGAGTGAGCACAAAGCTGTTTTGAAAAGACTCAAGGAGGAACAGACTCGAAAGTTAGCCATC
TTGGCTGAGCAGTATGATCATAGCATTAATGAAATGCTCTCCACACAAGCTCTGCGTTTGGATGAAGCAC
AGGAAGCAGAATGCCAGGTTCTGAAGATGCAGCTGCAGCAGGAACTGGAGCTGCTGAATGCTTATCAGAG
CAAAATAAAGATGCAAGCTGAGGCCCAACATGATCGAGAGCTTCGAGAGCTGGAACAGAGGGTCTCCCTT
CGCAGAGCGCTCTTAGAACAAAAGATTGAAGAAGAGATGTTGGCTTTGCAGAATGAACGCACAGAACGAA
TACGTAGCCTGCTCGAGCGTCAAGCCAGAGAAATTGAAGCATTTGACTCTGAAAGCATGAGATTAGGTTT
TAGTAACATGGTCCTTTCTAATCTCTCCCCTGAGGCATTCAGCCACAGCTACCCAGGAGCTTCTAGTTGG
TCTCACAATCCTACTGGGGGTCCAGGACCTCACTGGGGTCATCCCATGGGTGGCACACCACAAGCTTGGG
GTCATCCGATGCAAGGTGGACCCCAACCATGGGGTCATCCCTCAGGGCCAATGCAAGGGGTACCTCGAGG
TAGCAGTATGGGAGTCCGCAATAGCCCCCAGGCTTTGAGGCGGACAGCTTCTGGGGGACGGACGGAACAG
GGCATGAGCAGAAGCACGAGTGTCACTTCACAAATATCCAATGGGTCACACATGTCTTACACATAA


ACGCGTACGCGGCCGCTCGAGCAGAAACTCATCTCAGAAGAGGATCTGGCAGCAAATGATATCCTGGATT
ACAAGGATGACGACGATAAGGTTTAA
Restriction Sites SgfI-MluI     
ACCN NM_144825
Insert Size 3006 bp
OTI Disclaimer Our molecular clone sequence data has been matched to the reference identifier above as a point of reference. Note that the complete sequence of our molecular clones may differ from the sequence published for this corresponding reference, e.g., by representing an alternative RNA splicing form or single nucleotide polymorphism (SNP).
Product Components The ORF clone is ion-exchange column purified and shipped in a 2D barcoded Matrix tube containing 10ug of transfection-ready, dried plasmid DNA (reconstitute with 100 ul of water).
Reconstitution 1. Centrifuge at 5,000xg for 5min.
2. Carefully open the tube and add 100ul of sterile water to dissolve the DNA.
3. Close the tube and incubate for 10 minutes at room temperature.
4. Briefly vortex the tube and then do a quick spin (less than 5000xg) to concentrate the liquid at the bottom.
5. Store the suspended plasmid at -20°C. The DNA is stable for at least one year from date of shipping when stored at -20°C.
Reference Data
RefSeq NM_144825.2, NP_659074.2
RefSeq Size 12411 bp
RefSeq ORF 3006 bp
Locus ID 216965
UniProt ID Q5F2E8
Gene Summary Serine/threonine-protein kinase involved in various processes such as p38/MAPK14 stress-activated MAPK cascade, DNA damage response and regulation of cytoskeleton stability. Phosphorylates MAP2K3, MAP2K6 and MARK2. Acts as an activator of the p38/MAPK14 stress-activated MAPK cascade by mediating phosphorylation and subsequent activation of the upstream MAP2K3 and MAP2K6 kinases. Involved in G-protein coupled receptor signaling to p38/MAPK14. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of MAP2K3 and MAP2K6. Acts as a regulator of cytoskeleton stability by phosphorylating 'Thr-208' of MARK2, leading to activate MARK2 kinase activity and subsequent phosphorylation and detachment of MAPT/TAU from microtubules. Also acts as a regulator of apoptosis: regulates apoptotic morphological changes, including cell contraction, membrane blebbing and apoptotic bodies formation via activation of the MAPK8/JNK cascade (By similarity).[UniProtKB/Swiss-Prot Function]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Other Versions

Customer Reviews 
Loading...